Clinical trial
Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal…
NCT00194012 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00194012 |
|---|---|
| Title | Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder |
| Official title | Aripiprazole in At-Risk Children With Symptoms of Bipolar Disorder |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole, Placebo |
| Enrollment | 62 |
| Start date | Aug 1, 2004 |
| Primary completion | May 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Sep 19, 2005 |
| Last update posted | Jun 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: